182 related articles for article (PubMed ID: 29642629)
1. 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.
Hashimoto C; Miki Y; Tanaka S; Takagi K; Fue M; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642629
[TBL] [Abstract][Full Text] [Related]
2. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
Tanaka S; Miki Y; Hashimoto C; Takagi K; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
Mol Cell Endocrinol; 2015 Feb; 401():56-64. PubMed ID: 25475427
[TBL] [Abstract][Full Text] [Related]
3. 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.
Aka JA; Mazumdar M; Chen CQ; Poirier D; Lin SX
Mol Endocrinol; 2010 Apr; 24(4):832-45. PubMed ID: 20172961
[TBL] [Abstract][Full Text] [Related]
4. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A
J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553
[TBL] [Abstract][Full Text] [Related]
5. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
[TBL] [Abstract][Full Text] [Related]
6. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
[TBL] [Abstract][Full Text] [Related]
7. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
[TBL] [Abstract][Full Text] [Related]
10. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
11. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.
Zhang CY; Wang WQ; Chen J; Lin SX
J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817
[TBL] [Abstract][Full Text] [Related]
12. In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production.
Ito K; Miki Y; Suzuki T; McNamara KM; Sasano H
Endocr Relat Cancer; 2016 Jul; 23(7):R323-35. PubMed ID: 27287451
[TBL] [Abstract][Full Text] [Related]
13. Expression of steroidogenic enzymes in human sebaceous glands.
Inoue T; Miki Y; Kakuo S; Hachiya A; Kitahara T; Aiba S; Zouboulis CC; Sasano H
J Endocrinol; 2014 Sep; 222(3):301-12. PubMed ID: 24938708
[TBL] [Abstract][Full Text] [Related]
14. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
[TBL] [Abstract][Full Text] [Related]
15. The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma.
Utsunomiya H; Suzuki T; Ito K; Moriya T; Konno R; Sato S; Yaegashi N; Okamura K; Sasano H
Clin Endocrinol (Oxf); 2003 Jun; 58(6):696-703. PubMed ID: 12780745
[TBL] [Abstract][Full Text] [Related]
16. Effects of SNP variants in the 17β-HSD2 and 17β-HSD7 genes and 17β-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue.
Straume AH; Knappskog S; Lønning PE
J Steroid Biochem Mol Biol; 2014 Sep; 143():192-8. PubMed ID: 24560990
[TBL] [Abstract][Full Text] [Related]
17. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
Gan Q; Crumley S; Broaddus RR
Int J Gynecol Pathol; 2019 Jan; 38(1):44-51. PubMed ID: 29210800
[TBL] [Abstract][Full Text] [Related]
18. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
Sang X; Han H; Li T; Lin SX
J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
20. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
